How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Telehealth Modernization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2022 · fourth_quarter · Q4
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Source: Senate LDA
Telehealth Modernization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Telehealth Modernization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Telehealth Modernization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Dr. Lorna Breen Health Care Provider Protection Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Medicare Prescription Drug Price Negotiation Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Medicare Prescription Drug Price Negotiation Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Medicare Prescription Drug Price Negotiation Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Medicare Prescription Drug Price Negotiation Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
S. 464/ H.R. 2163: Safe Step Act
S. 464/ H.R. 2163: Safe Step Act
S. 464/ H.R. 2163: Safe Step Act
S. 464/ H.R. 2163: Safe Step Act
Healthcare Workforce Resilience Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Healthcare Workforce Resilience Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Healthcare Workforce Resilience Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Healthcare Workforce Resilience Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Resident Physician Shortage Reduction Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Resident Physician Shortage Reduction Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Resident Physician Shortage Reduction Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Resident Physician Shortage Reduction Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
COVID–19 Long Haulers Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
COVID–19 Long Haulers Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
COVID–19 Long Haulers Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
COVID–19 Long Haulers Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
ENACT Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
ENACT Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
ENACT Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
ENACT Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Improving Seniors’ Timely Access to Care Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Improving Seniors’ Timely Access to Care Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Improving Seniors’ Timely Access to Care Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Improving Seniors’ Timely Access to Care Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Conrad State 30 and Physician Access Reauthorization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Conrad State 30 and Physician Access Reauthorization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Conrad State 30 and Physician Access Reauthorization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Conrad State 30 and Physician Access Reauthorization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Inflation Reduction Act of 2022
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Inflation Reduction Act of 2022
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Inflation Reduction Act of 2022
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Inflation Reduction Act of 2022
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
BRAIN Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
BRAIN Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
BRAIN Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
BRAIN Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Supporting Medicare Providers Act of 2022
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Supporting Medicare Providers Act of 2022
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Healthcare Workforce Resilience Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Healthcare Workforce Resilience Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Healthcare Workforce Resilience Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Healthcare Workforce Resilience Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
CONNECT for Health Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
CONNECT for Health Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
CONNECT for Health Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
CONNECT for Health Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Conrad State 30 and Physician Access Reauthorization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Conrad State 30 and Physician Access Reauthorization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Conrad State 30 and Physician Access Reauthorization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Conrad State 30 and Physician Access Reauthorization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Neuroscience Center of Excellence Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Neuroscience Center of Excellence Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Neuroscience Center of Excellence Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Neuroscience Center of Excellence Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Telehealth Modernization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Telehealth Modernization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Telehealth Modernization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Telehealth Modernization Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
FDASLA Act of 2022
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
FDASLA Act of 2022
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
FDASLA Act of 2022
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
S. 464/ H.R. 2163: Safe Step Act
S. 464/ H.R. 2163: Safe Step Act
S. 464/ H.R. 2163: Safe Step Act
S. 464/ H.R. 2163: Safe Step Act
National Neurological Conditions Surveillance System Reauthorization Act of 2022
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
National Neurological Conditions Surveillance System Reauthorization Act of 2022
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Protecting Medicare and American Farmers from Sequester Cuts Act
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Empowering Medicare Seniors to Negotiate Drug Prices Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Empowering Medicare Seniors to Negotiate Drug Prices Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Empowering Medicare Seniors to Negotiate Drug Prices Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Empowering Medicare Seniors to Negotiate Drug Prices Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Resident Physician Shortage Reduction Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Resident Physician Shortage Reduction Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Resident Physician Shortage Reduction Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Resident Physician Shortage Reduction Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Fair Accountability and Innovative Research Drug Pricing Act of 2021
Client: AMERICAN ACADEMY OF NEUROLOGY · Firm: AMERICAN ACADEMY OF NEUROLOGY
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
S. 464/ H.R. 2163: Safe Step Act
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2022 · third_quarter · Q3
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
S. 464/ H.R. 2163: Safe Step Act
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2022 · second_quarter · Q2
S. 464/ H.R. 2163: Safe Step Act
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2022 · first_quarter · Q1
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program.
S. 464/ H.R. 2163: Safe Step Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2021 · fourth_quarter · Q4
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program.
S. 368/ H.R. 1332: Telehealth Modernization Act S. 754/ H.R. 1916: Ensuring Lasting Smiles Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 S. 1988/H.R. 5425: Protecting Rural Telehealth Access Act H.R. 366: Protecting Access to Post-COVID-19 Telehealth Act H.R. 3173: Improving Seniors Timely Access to Care Act H.R. 3447: Permanency for Audio-Only Telehealth Act H.R. 4040: Advancing Telehealth Beyond Covid-19 Act S. 610: Protecting Medicare and American Farmers from Sequester Cuts Act S. 1731: Medicare Audiologist Access and Services Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D.
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S.1692/H.R.3354: Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 H.R. 5657: Medical Marijuana Research Act Supporting vaccine requirements for health care workers. Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding the CDC National Neurological Conditions Surveillance System. Medical research funding related to fetal tissue, AHRQ, Congressionally Directed Medical Research Programs at the Department of Defense, and the NIH including the BRAIN Initiative. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
H.R. 2079: The Eliminating the Provider Relief Fund Tax Penalties Act of 2021
S. 464/ H.R. 2163: Safe Step Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2021 · third_quarter · Q3
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S. 1692/H.R.3354: Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding the CDC National Neurological Conditions Surveillance System. Medical research funding related to fetal tissue, AHRQ, Congressionally Directed Medical Research Programs at the Department of Defense, and the NIH including the BRAIN Initiative. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2021 · second_quarter · Q2
S. 464/ H.R. 2163: Safe Step Act
S. 368/ H.R. 1332: Telehealth Modernization Act S. 748: Medicare Sequester Relief Act S. 754/ H.R. 1916: Ensuring Lasting Smiles Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 366: Protecting Access to Post-COVID-19 Telehealth Act H.R. 3173: Improving Seniors Timely Access to Care Act Support extension of 3.75% increase to Medicare Physician Fee Schedule payments Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments, postponing Medicare sequestration cuts beyond 2021, and retaining telemedicine. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2021 · first_quarter · Q1
S. 368/ H.R. 1332: Telehealth Modernization Act S. 748: Medicare Sequester Relief Act S. 754/ H.R. 1916: Ensuring Lasting Smiles Act S. 833/ H.R. 2071 Empowering Medicare Seniors to Negotiate Drug Prices Act H.R. 315: The Medicare Sequester COVID Moratorium Act H.R. 366: Protecting Access to Post-COVID-19 Telehealth Act H.R. 1868: To prevent across-the-board direct spending cuts, and for other purposes. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including expanding telemedicine, support for physician practices, and regulatory relief. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Opposition for changes to the Six Protected Classes in Medicare Part D.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2020 · fourth_quarter · Q4
S. 3988: The Enhancing Preparedness Through Telehealth Act; all provisions. S. 2741/ H.R. 4932: CONNECT for Health Act; all provisions. S. 5007/ H.R. 8702: The Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020 S. 5044/ H.R. 3107: Improving Seniors' Timely Access to Care Act; all provisions. H.R. 133: The Consolidated Appropriations Act, 2021, Division CC Health Care Extenders. H.R. 7391, The Protect Telehealth Access Act; all provisions. H.R. 7663: Protecting Access to Post-COVID-19 Telehealth Act; all provisions. H.R. 8505: To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes; all provisions. Supporting the implementation of CMSs final rule on Evaluation and Management (E/M) billing codes. Supporting policies to address the COVID-19 pandemic, including expanding telemedicine, support for physician practices, and regulatory relief. Supporting a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. Improvements to the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015. Medicare coverage of oxygen therapy for cluster headaches. Advocating for reform to stark and anti-kickback laws to promote value-based payment arrangements. Opposing Most Favored Nation Model for Medicare Part B Drugs and Biologicals. Supporting extending moratorium on Medicare sequestration cuts.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2020 · third_quarter · Q3
S. 348/H.R. 1763 Resident Physician Shortage Reduction Act of 2019; all provisions. S. 2443: Investment in Tomorrow's Pediatric Health Care Workforce Act; all provisions. S. 2546 / H.R. 2279: Safe Step Act; all provisions. S. 3741/ H.R. 6644: The Health Care at Home Act; all provisions. S. 3993: The Equal Access to Care Act; all provisions. S. 4421/ H.R. 8283: the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act. S. 7819/H.R. 4525 Eliminating the Provider Relief Fund Tax Penalties Act of 2020; all provisions. H.R. 2781: Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act, section 4. H.R. 748: Coronavirus Aid, Relief and Economic Security (CARES) Act; Title III. H.R. 3502: Protecting People from Surprise Medical Bills Act; all provisions. H.R. 6800: The Heroes Act; Title VI and Title X Division C. H.R. 7059: The Coronavirus Provider Protection Act; all provisions. H.R. 7255: Coronavirus Health Care Worker Wellness Act of 2020; all provisions. Supporting policies to address the COVID-19 public health emergency, including funding for personal protective equipment, maintaining telemedicine coverage, ensuring access to affordable health coverage, and medical liability flexibility relating to COVID-19. Funding for the CDC National Neurological Conditions Surveillance System. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, AHRQ, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Lifting the federal ban restricting HHS from studying a Universal Patient Identifier. Policy to address surprise medical billing. Promoting interoperability in electronic health records. Maintain work authorization for individuals currently in DACA status during the COVID-19 national emergency and other policies to support health care providers who live, work, and train in the United States but are not US citizens
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2020 · second_quarter · Q2
Strengthening the VA Centers of Excellence
H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions. H.R. 4932/ S. 2741: CONNECT for Health Act; all provisions. S. 3988, The Enhancing Preparedness Through Telehealth Act; all provisions. Supporting the implementation of CMSs final rule on Evaluation and Management (E/M) billing codes. Supporting policies to address the COVID-19 pandemic, including expanding telemedicine, support for physician practices, and regulatory relief. Supporting a permeant expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. Improvements to the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015. Medicare coverage of oxygen therapy for cluster headaches. Advocating for reform to stark and anti-kickback laws to promote value-based payment arrangements.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2020 · first_quarter · Q1
S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 2387: We Protect American Investment in Drugs (PAID) Act; all provisions. S. 2443: Investment in Tomorrow's Pediatric Health Care Workforce Act; all provisions. S. 2546 / H.R. 2279: Safe Step Act; all provisions. H.R. 1379: the Ensuring Lasting Smiles Act; all provisions. H.R. 2781: Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act, section 4. H.R. 3502: Protecting People from Surprise Medical Bills Act; all provisions. H.R. 6074: Coronavirus Preparedness and Response Supplemental Appropriations Act; all provisions. H.R. 6201: Families First Coronavirus Response Act; all provisions. Supporting policies to address prescription drug costs, including funding for personal protective equipment and expanding telemedicine. Funding for the CDC National Neurological Conditions Surveillance System. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, AHRQ, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Lifting the federal ban restricting HHS from studying a Universal Patient Identifier. Policy to address surprise medical billing. Promoting interoperability in electronic health records.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2019 · second_quarter · 2A
Strengthening the VA Centers of Excellence
H.R. 88; Section 505: Repeal of Unrelated Business Income Tax on Qualified Transportation Fringe Benefits
S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2019 · fourth_quarter · Q4
S. 2543: Prescription Drug Pricing Reduction Act; sections 102, 107, 110, 121, 128, 141. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act; all provisions. H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions. H.R.4945: Safeguarding Medicare Access to Respiratory Therapy Act of 2019; all provisions. Supporting CMSs final rule on Evaluation and Management (E/M) billing codes. Recommending various changes to the CMS proposed rule on long-term electroencephalogram (EEG) billing codes. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. Improvements to the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015. Medicare coverage of oxygen therapy for cluster headaches. Advocating for reform to stark and anti-kickback laws to promote value-based payment arrangements.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2019 · third_quarter · Q3
S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S.1622, Stopping Overdoses of Fentanyl Analogues Act; all provisions. S.2546 / H.R. 2279: Safe Step Act; all provisions. H.R. 2471: Healthcare Extension and Accessibility for Developmentally Disabled and Underserved Population Act of 2019; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. HR 3502, Protecting People from Surprise Medical Bills Act; all provisions. Authorizing and funding the pediatric loan repayment program. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2019 · second_quarter · Q2
S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act; all provisions. H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019; all provisions. H.R. 2282: Medicare Care Coordination Improvement Act of 2019; all provisions. H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. CMS proposed rule altering Evaluation and Management billing codes. Issues associated with defining a rehabilitation physician within the inpatient rehabilitation setting. Improvements to the Medicare Access and CHIP Reauthorization Act of 2015. Appropriate use criteria for imaging services. Medicare coverage of oxygen therapy for cluster headaches.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2019 · first_quarter · Q1
S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 348/H.R. 1763: The Resident Physician Shortage Reduction Act of 2019 S. 560/H.R. 1379: the Ensuring Lasting Smiles Act S. 966/ H.R. 2282: Medicare Care Coordination Improvement Act H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019 Valuation of Long-term Electroencephalogram monitoring; Issues associated with Qualified Clinical Data Registry implementation, measure licensing, approval, removal, benchmarking, and revision; Eliminating or streamlining requirements for prior authorization or step therapy; CMS proposed rule altering Evaluation and Management billing codes; appropriate use criteria for imaging services; Medicare coverage of oxygen therapy for cluster headaches.
H.R. 88; Section 505: Repeal of Unrelated Business Income Tax on Qualified Transportation Fringe Benefits
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2018 · fourth_quarter · 4A
H.R. 88; Section 505: Repeal of Unrelated Business Income Tax on Qualified Transportation Fringe Benefits
S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 2908: Legislation to improve electronic prior authorization use in Medicare Advantage S. 2051/H.R. 4206: Medicare Care Coordination Improvement Act H.R. 4841: Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018 Qualified clinical data registries (QCDR) measure licensing; Step Therapy in Medicare Advantage; CMS proposed rule altering Evaluation and Management billing codes; appropriate use criteria for imaging services; CDC Neurological Conditions Surveillance System funding; Medicare coverage of oxygen therapy for cluster headaches.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2018 · third_quarter · 3A
S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 2908: Legislation to improve electronic prior authorization use in Medicare Advantage S. 2051/H.R. 4206: Medicare Care Coordination Improvement Act H.R. 4841: Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018 Step Therapy in Medicare Advantage; CMS proposed rule altering Evaluation and Management billing codes; appropriate use criteria for imaging services; Medicare coverage of oxygen therapy for cluster headaches.
S. 92: Safe and Affordable Drugs from Canada Act S. 469: Affordable and Safe Prescription Drug Importation Act S. 1131/ H.R. 2439: FAIR Drug Pricing Act S. 1348: SPIKE Act of 2017 S. 1369/ H.R. 2974: Stop Price Gouging Act S. 2260 / H.R. 4733: Opioids and STOP Pain Initiative Act S. 2406: Advancing Cutting Edge (ACE) Research Act S. 2478: End Taxpayer Subsidies for Drug Ads Act S. 2680: Opioid Crisis Response Act S. 2891: Fighting the Opioid Epidemic with Sunshine Act S. 3369/ H.R. 6689: Ensuring Lasting Smiles Act S. 3411: Affordable Medications Act H.R. 6: SUPPORT for Patients and Communities Act: Sections 6062 and 6111; Subtitle E H.R. 1776: Improving Access to Affordable Prescription Drugs Act H.R. 2077: Restoring the Patient's Voice Act H.R. 4116: Transparent Drug Pricing Act H.R. 5634: Medical Cannabis Research Act H.R. 6340: Capping Prescription Costs Act Interoperability, including for Qualified Clinical Data Registries; Appropriations for the CDC National Neurological Conditions Surveillance System; Maintenance/expansion of Graduate Medical Education (GME); NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2018 · second_quarter · 2A
S. 2575: Audiology Patient Choice Act of 2018 S. 2908: Legislation to improve electronic prior authorization use in Medicare Advantage S. 3120: Helping to End Addiction and Lessen (HEAL) Substance Use Disorders Act of 2018 H.R. 4841: Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018 Preservation of the in-office ancillary exception to the Stark law; appropriate use criteria for imaging services; Medicare coverage of oxygen therapy for cluster headaches.
S. 92: Safe and Affordable Drugs from Canada Act S. 201 / H.R. 5247: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 S. 469: Affordable and Safe Prescription Drug Importation Act S. 1131/ H.R. 2439: FAIR Drug Pricing Act S. 2260 / H.R. 4733: Opioids and STOP Pain Initiative Act H.R. 1776: Improving Access to Affordable Prescription Drugs Act H.R. 1876: Good Samaritan Health Professionals Act of 2017 H.R. 2077: the Restoring the Patient's Voice Act of 2017 H.R. 4116: Transparent Drug Pricing Act of 2017 S. 2387 / H.R. 4957: Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act S. 2406: Advancing Cutting Edge (ACE) Research Act S. 2478: End Taxpayer Subsidies for Drug Ads Act S. 2680: Opioid Crisis Response Act of 2018 S. 2891: Fighting the Opioid Epidemic with Sunshine Act H.R. 5634: Medical Cannabis Research Act Maintenance/expansion of Graduate Medical Education (GME); encouraging drug price transparency; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2018 · first_quarter · 1A
S. 260 / H.R. 849: Protecting Seniors Access to Medicare Act S. 431 / H.R. 1148: Furthering Access to Stroke Telemedicine (FAST) Act S. 870 / H.R. 4579: CHRONIC Care Act S. 1016 / H.R. 2556: CONNECT for Health Act Preservation of the in-office ancillary exception to the Stark law; appropriate use criteria for imaging services; Medicare coverage of oxygen therapy for cluster headaches; urging changes to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
S. 92: Safe and Affordable Drugs from Canada Act S. 201 / H.R. 5247: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 S. 469: Affordable and Safe Prescription Drug Importation Act S. 1131/ H.R. 2439: FAIR Drug Pricing Act S. 1827/ H.R. 3921 HEALTHY KIDS Act S. 2076 /H.R. 4256: Building Our Largest Dementia (BOLD) Infrastructure for Alzheimers Act S. 2260 / H.R. 4733: Opioids and STOP Pain Initiative Act H.R. 1625 Vehicle for Consolidated Appropriations Act 2018 H.R. 1776: Improving Access to Affordable Prescription Drugs Act H.R. 1876: Good Samaritan Health Professionals Act of 2017 H.R. 1892: Continuing Resolution through March 23, 2018 H.R. 2077: the Restoring the Patient's Voice Act of 2017 H.R. 4116: Transparent Drug Pricing Act of 2017 H.R. 4841: Legislation to improve electronic prior authorization use in Medicare Advantage Maintenance/expansion of Graduate Medical Education (GME); encouraging drug price transparency; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2018 · fourth_quarter · Q4
S. 92: Safe and Affordable Drugs from Canada Act S. 469: Affordable and Safe Prescription Drug Importation Act S. 1131/ H.R. 2439: FAIR Drug Pricing Act S. 1348: SPIKE Act of 2017 S. 1369/ H.R. 2974: Stop Price Gouging Act S. 1803/H.R. 4825, the Marijuana Effective Drug Studies (MEDS) Act S. 2076/H.R. 4256: BOLD Infrastructure for Alzheimer's Act S. 2406: Advancing Cutting Edge (ACE) Research Act S. 2478: End Taxpayer Subsidies for Drug Ads Act S. 2680: Opioid Crisis Response Act S. 2891: Fighting the Opioid Epidemic with Sunshine Act S. 3369/ HR 6689: Ensuring Lasting Smiles Act S. 3411/H.R. 6689: Affordable Medications Act S. 3657/ H.R. 6615: Traumatic Brain Injury Program Reauthorization Act S. 3686/ H.R. 3580: Protecting Student Athletes from Concussions Act H.R. 6: SUPPORT for Patients and Communities Act: Sections 6062 and 6111; Subtitle E H.R. 1776: Improving Access to Affordable Prescription Drugs Act H.R. 2077: Restoring the Patient's Voice Act H.R. 3391, Medical Marijuana Research Act of 2017 H.R. 4116: Transparent Drug Pricing Act H.R. 5634: Medical Cannabis Research Act H.R. 6340: Capping Prescription Costs Act Disclosure of drug prices in prescription drug direct-to-consumer advertising; Sustained fetal tissue research; Orphan Drug Act Reform; Interoperability, including for Qualified Clinical Data Registries; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues; loan repayment for pediatric specialists.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2018 · third_quarter · Q3
S. 92: Safe and Affordable Drugs from Canada Act S. 469: Affordable and Safe Prescription Drug Importation Act S. 1131/ H.R. 2439: FAIR Drug Pricing Act S. 1348: SPIKE Act of 2017 S. 1369/ H.R. 2974: Stop Price Gouging Act S. 2260 / H.R. 4733: Opioids and STOP Pain Initiative Act S. 2406: Advancing Cutting Edge (ACE) Research Act S. 2478: End Taxpayer Subsidies for Drug Ads Act S. 2680: Opioid Crisis Response Act S. 2891: Fighting the Opioid Epidemic with Sunshine Act S. 3369/ H.R. 6689: Ensuring Lasting Smiles Act S. 3411: Affordable Medications Act H.R. 6: SUPPORT for Patients and Communities Act: Sections 6062 and 6111; Subtitle E H.R. 1776: Improving Access to Affordable Prescription Drugs Act H.R. 2077: Restoring the Patient's Voice Act H.R. 4116: Transparent Drug Pricing Act H.R. 5634: Medical Cannabis Research Act H.R. 6340: Capping Prescription Costs Act Interoperability, including for Qualified Clinical Data Registries; Appropriations for the CDC National Neurological Conditions Surveillance System; Maintenance/expansion of Graduate Medical Education (GME); NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2018 · second_quarter · Q2
S. 92: Safe and Affordable Drugs from Canada Act S. 201 / H.R. 5247: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 S. 469: Affordable and Safe Prescription Drug Importation Act S. 1131/ H.R. 2439: FAIR Drug Pricing Act S. 2260 / H.R. 4733: Opioids and STOP Pain Initiative Act H.R. 1776: Improving Access to Affordable Prescription Drugs Act H.R. 1876: Good Samaritan Health Professionals Act of 2017 H.R. 2077: the Restoring the Patient's Voice Act of 2017 H.R. 4116: Transparent Drug Pricing Act of 2017 S. 2387 / H.R. 4957: Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act S. 2406: Advancing Cutting Edge (ACE) Research Act S. 2478: End Taxpayer Subsidies for Drug Ads Act S. 2680: Opioid Crisis Response Act of 2018 S. 2891: Fighting the Opioid Epidemic with Sunshine Act H.R. 5634: Medical Cannabis Research Act Maintenance/expansion of Graduate Medical Education (GME); encouraging drug price transparency; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2018 · first_quarter · Q1
S. 92: Safe and Affordable Drugs from Canada Act S. 201 / H.R. 5247: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 S. 469: Affordable and Safe Prescription Drug Importation Act S. 1131/ H.R. 2439: FAIR Drug Pricing Act S. 1827/ H.R. 3921 HEALTHY KIDS Act S. 2076 /H.R. 4256: Building Our Largest Dementia (BOLD) Infrastructure for Alzheimers Act S. 2260 / H.R. 4733: Opioids and STOP Pain Initiative Act H.R. 1625 Vehicle for Consolidated Appropriations Act 2018 H.R. 1776: Improving Access to Affordable Prescription Drugs Act H.R. 1876: Good Samaritan Health Professionals Act of 2017 H.R. 1892: Continuing Resolution through March 23, 2018 H.R. 2077: the Restoring the Patient's Voice Act of 2017 H.R. 4116: Transparent Drug Pricing Act of 2017 H.R. 4841: Legislation to improve electronic prior authorization use in Medicare Advantage Maintenance/expansion of Graduate Medical Education (GME); encouraging drug price transparency; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2017 · fourth_quarter · 4A
S. 260 / H.R. 849: Protecting Seniors Access to Medicare Act S. 431 / H.R. 1148: Furthering Access to Stroke Telemedicine (FAST) Act S. 870 / H.R. 4579: CHRONIC Care Act S. 1016 / H.R. 2556: CONNECT for Health Act S. 2051: The Medicare Care Coordination Improvement Act of 2017 Preservation of the in-office ancillary exception to the Stark law; appropriate use criteria for imaging services; Medicare coverage of Oxygen therapy for cluster headaches; urging changes to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
S. 92: Safe and Affordable Drugs from Canada Act S. 469: Affordable and Safe Prescription Drug Importation Act S. 771 / H.R. 1776: Improving Access to Affordable Prescription Drugs Act S. 808: Sports Medicine Licensure Clarity Act S. 989/ H.R. 3767: Ensuring Childrens Access to Specialty Care Act S. 1131/ H.R. 2439: FAIR Drug Pricing Act S. 1827/ H.R. 3921 HEALTHY KIDS Act S. 2260 / H.R. 4733: Opioids and STOP Pain Initiative Act H.R. 3197: PUPPERS Act H.R. 3928: Truth in Healthcare Marketing Act of 2017 H.R. 4116: Transparent Drug Pricing Act of 2017 Reauthorization of the Pediatric Subspecialty Loan Repayment Program in Title VII; Maintenance/expansion of Graduate Medical Education (GME); CDC funding; NIH funding including the BRAIN Initiative; DACA renewal; Congressionally-Directed Medical Research Program funding; concussion related issues.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2017 · third_quarter · 3A
S. 260 / H.R. 849: Protecting Seniors Access to Medicare Act S. 431 / H.R. 1148: Furthering Access to Stroke Telemedicine (FAST) Act S. 794 / H.R. 3635: Local Coverage Determination Clarification Act S. 870: CHRONIC Care Act S. 1016 / H.R. 2556: CONNECT for Health Act H.R. 1628: American Health Care Act, an amendment in the nature of a substitute [LYN17744] H.R. 2276: Audiology Patient Choice Act Preservation of the in-office ancillary exception to the Stark law; Medicare Red Tape Relief Project; appropriate use criteria for imaging services; Medicare coverage of Oxygen therapy for cluster headaches; urging changes to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
S. 92: Safe and Affordable Drugs from Canada Act S. 469: Affordable and Safe Prescription Drug Importation Act S. 989 Ensuring Childrens Access to Specialty Care Act S. 1827/ H.R. 3921 HEALTHY KIDS Act H.R. 1215: Protecting Access to Care Act H.R. 2439/S. 1131: FAIR Drug Pricing Act H.R. 1776/S. 771: Improving Access to Affordable Prescription Drugs Act Reauthorization of the Pediatric Subspecialty Loan Repayment Program in Title VII; maintenance/expansion of Graduate Medical Education (GME); CDC funding; NIH funding including the BRAIN Initiative; concussion related issues.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2017 · second_quarter · 2A
S. 92: Safe and Affordable Drugs from Canada Act of 2017 S. 469: Affordable and Safe Prescription Drug Importation Act H.R. 714: Legitimate Use of Medicinal Marijuana Act S. 794: Local Coverage Determination Act of 2017 H.R. 2276: Audiology Patient Choice Act of 2017 H.R. 2439/S. 1131: FAIR Drug Pricing Act H.R. 1776/S. 771: Improving Access to Affordable Prescription Drugs Act Maintenance/expansion of Graduate Medical Education (GME); NIH funding including the BRAIN Initiative; concussion related issues.
S. 431 / H.R. 1148: Furthering Access to Stroke Telemedicine (FAST) Act S. 870: CHRONIC Care Act H.R. 1565: Saving Lives, Saving Costs Act H.R. 1628: American Health Care Act S. 260 / H.R. 849: Protecting Seniors Access to Medicare Act of 2017 CONNECT for Health Act; Preservation of the in-office ancillary exception to the Stark law; Medicare coverage of Oxygen therapy for cluster headaches; urging changes to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2017 · first_quarter · 1A
S. 92: Safe and Affordable Drugs from Canada Act of 2017 S. 469: Affordable and Safe Prescription Drug Importation Act H.R. 714: Legitimate Use of Medicinal Marijuana Act Maintenance/expansion of Graduate Medical Education (GME); NIH funding including the BRAIN Initiative; concussion related issues.
S. 431 / H.R. 1148: Furthering Access to Stroke Telemedicine (FAST) Act S. 870: CHRONIC Care Act H.R. 1565: Saving Lives, Saving Costs Act H.R. 1628: American Health Care Act S. 260 / H.R. 849: Protecting Seniors Access to Medicare Act of 2017 CONNECT for Health Act; Preservation of the in-office ancillary exception to the Stark law; Medicare coverage of Oxygen therapy for cluster headaches; urging changes to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2017 · fourth_quarter · Q4
H.R. 1. Preservation of deductibility of student loan interest and medical expenses; Preservation of tax-exempt status for graduate tuition waivers; opposition to repealing the individual mandate.
Preserving national funding for the Epilepsy Centers of Excellence.
S. 92: Safe and Affordable Drugs from Canada Act S. 469: Affordable and Safe Prescription Drug Importation Act S. 771 / H.R. 1776: Improving Access to Affordable Prescription Drugs Act S. 808: Sports Medicine Licensure Clarity Act S. 989/ H.R. 3767: Ensuring Childrens Access to Specialty Care Act S. 1131/ H.R. 2439: FAIR Drug Pricing Act S. 1827/ H.R. 3921 HEALTHY KIDS Act S. 2260 / H.R. 4733: Opioids and STOP Pain Initiative Act H.R. 3197: PUPPERS Act H.R. 3928: Truth in Healthcare Marketing Act of 2017 H.R. 4116: Transparent Drug Pricing Act of 2017 Reauthorization of the Pediatric Subspecialty Loan Repayment Program in Title VII; Maintenance/expansion of Graduate Medical Education (GME); CDC funding; NIH funding including the BRAIN Initiative; DACA renewal; Congressionally-Directed Medical Research Program funding; concussion related issues.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2017 · third_quarter · Q3
S. 260 / H.R. 849: Protecting Seniors Access to Medicare Act S. 431 / H.R. 1148: Furthering Access to Stroke Telemedicine (FAST) Act S. 794 / H.R. 3635: Local Coverage Determination Clarification Act S. 870: CHRONIC Care Act S. 1016 / H.R. 2556: CONNECT for Health Act H.R. 1628: American Health Care Act, an amendment in the nature of a substitute [LYN17744] H.R. 2276: Audiology Patient Choice Act Preservation of the in-office ancillary exception to the Stark law; Medicare Red Tape Relief Project; appropriate use criteria for imaging services; Medicare coverage of Oxygen therapy for cluster headaches; urging changes to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
S. 92: Safe and Affordable Drugs from Canada Act S. 469: Affordable and Safe Prescription Drug Importation Act S. 989 Ensuring Childrens Access to Specialty Care Act S. 1827/ H.R. 3921 HEALTHY KIDS Act H.R. 1215: Protecting Access to Care Act H.R. 2439/S. 1131: FAIR Drug Pricing Act H.R. 1776/S. 771: Improving Access to Affordable Prescription Drugs Act Reauthorization of the Pediatric Subspecialty Loan Repayment Program in Title VII; maintenance/expansion of Graduate Medical Education (GME); CDC funding; NIH funding including the BRAIN Initiative; concussion related issues.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2017 · second_quarter · Q2
S. 92: Safe and Affordable Drugs from Canada Act of 2017 S. 469: Affordable and Safe Prescription Drug Importation Act H.R. 714: Legitimate Use of Medicinal Marijuana Act S. 794: Local Coverage Determination Act of 2017 H.R. 2276: Audiology Patient Choice Act of 2017 H.R. 2439/S. 1131: FAIR Drug Pricing Act H.R. 1776/S. 771: Improving Access to Affordable Prescription Drugs Act Maintenance/expansion of Graduate Medical Education (GME); NIH funding including the BRAIN Initiative; concussion related issues.
S. 431 / H.R. 1148: Furthering Access to Stroke Telemedicine (FAST) Act S. 870: CHRONIC Care Act H.R. 1565: Saving Lives, Saving Costs Act H.R. 1628: American Health Care Act S. 260 / H.R. 849: Protecting Seniors Access to Medicare Act of 2017 CONNECT for Health Act; Preservation of the in-office ancillary exception to the Stark law; Medicare coverage of Oxygen therapy for cluster headaches; urging changes to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2017 · first_quarter · Q1
S. 431 / H.R. 1148: Furthering Access to Stroke Telemedicine (FAST) Act S. 870: CHRONIC Care Act H.R. 1565: Saving Lives, Saving Costs Act H.R. 1628: American Health Care Act S. 260 / H.R. 849: Protecting Seniors Access to Medicare Act of 2017 CONNECT for Health Act; Preservation of the in-office ancillary exception to the Stark law; Medicare coverage of Oxygen therapy for cluster headaches; urging changes to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
S. 92: Safe and Affordable Drugs from Canada Act of 2017 S. 469: Affordable and Safe Prescription Drug Importation Act H.R. 714: Legitimate Use of Medicinal Marijuana Act Maintenance/expansion of Graduate Medical Education (GME); NIH funding including the BRAIN Initiative; concussion related issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2016 · fourth_quarter · 4A
S. 1465 / HR 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 2484 / HR 4442: CONNECT for Health Act; Section 303 S.3504: CHRONIC Care Act of 2016 HR 2948: Medicare Telehealth Parity Act of 2015, Section 105(a)(1) HR 5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models. Preservation of the in-office ancillary exception to the Stark law; urging changes to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
S. 849 / HR 292: The Advancing Research for Neurological Diseases Act S. 2873 / HR 5395: The Expanding Capacity for Health Outcomes (ECHO) for Act HR 34: 21st Century Cures Act Maintenance/expansion of Graduate Medical Education (GME); NIH funding, concussion related issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2016 · third_quarter · 3A
S. 1465 / HR 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 2484 / HR 4442: CONNECT for Health Act; Section 303 HR 2948: Medicare Telehealth Parity Act of 2015, Section 105(a)(1) HR 5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models. Preservation of the in-office ancillary exception to the Stark law; urging changes to the Meaningful Use Program and Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
S. 849 / HR 292: The Advancing Research for Neurological Diseases Act S. 2873 / HR 5395: The Expanding Capacity for Health Outcomes (ECHO) for Act S. 2943: National Defense Authorization Act for Fiscal Year 2017, Section 705 S. 2978: Protect Continuing Physician Education and Patient Care Act HR 6: 21st Century Cures Act, Title 1, and Sections 1122, & 3021 HR 6010: Zika Pregnancy and Infant Registry Act of 2016 Maintenance/expansion of Graduate Medical Education (GME); NIH and Zika Funding; concussion related issues.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2016 · second_quarter · 2A
S. 2511: Improving Health Information Technology Act S. 1465 / HR 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 2484: HR 4442: CONNECT for Health Act; Section 303 S. 2978: Protect Continuing Physician Education and Patient Care Act HR 2948: Medicare Telehealth Parity Act of 2015, Section 105(a)(1) HR 5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models. Preservation of the in-office ancillary exception to the Stark law; urging changes to the Meaningful Use Program and Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
S. 2508/ HR 4460: Youth Sports Concussion Act HR 6: 21st Century Cures Act, Title 1, and Sections 1122, & 3021 S. 2782/ HR 1859: Ensuring Childrens Access to Specialty Care Act S. 849 / HR 292: The Advancing Research for Neurological Diseases Act S. 2873 / HR 5395: The Expanding Capacity for Health Outcomes (ECHO) for Act HR 5366: Alzheimers Breakthrough Sunshine Act Maintenance/expansion of Graduate Medical Education (GME); NIH Funding; concussion related issues.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2016 · first_quarter · 1A
S. 2508/ HR 4460: Youth Sports Concussion Act H.R. 6: 21st Century Cures Act, Title 1, and Sections 1122, & 3021 H.R. 1600: Patients' Access to Treatments Act of 2015 Maintenance/expansion of Graduate Medical Education (GME); NIH Funding; concussion related issues
S. 737/ H.R. 2253: Ensuring Access to Primary Care for Women & Children Act S. 849 / H.R. 292: The Advancing Research for Neurological Diseases Act S. 1465 / H.R. 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 2118: Ensuring Enhanced Access to Primary Care Act S. 2484/ H.R. 4442: CONNECT for Health Act; Section 303 H.R. 2948: Medicare Telehealth Parity Act of 2015, Section 105(a)(1) Preservation of the in-office ancillary exception to the Stark law; urging changes to the Meaningful Use Program.
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2016 · fourth_quarter · Q4
S. 1465 / HR 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 2484 / HR 4442: CONNECT for Health Act; Section 303 S.3504: CHRONIC Care Act of 2016 HR 2948: Medicare Telehealth Parity Act of 2015, Section 105(a)(1) HR 5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models. Preservation of the in-office ancillary exception to the Stark law; urging changes to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
S. 849 / HR 292: The Advancing Research for Neurological Diseases Act S. 2873 / HR 5395: The Expanding Capacity for Health Outcomes (ECHO) for Act HR 34: 21st Century Cures Act Maintenance/expansion of Graduate Medical Education (GME); NIH funding, concussion related issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2016 · third_quarter · Q3
S. 849 / HR 292: The Advancing Research for Neurological Diseases Act S. 2873 / HR 5395: The Expanding Capacity for Health Outcomes (ECHO) for Act S. 2943: National Defense Authorization Act for Fiscal Year 2017, Section 705 S. 2978: Protect Continuing Physician Education and Patient Care Act HR 6: 21st Century Cures Act, Title 1, and Sections 1122, & 3021 HR 6010: Zika Pregnancy and Infant Registry Act of 2016 Maintenance/expansion of Graduate Medical Education (GME); NIH and Zika Funding; concussion related issues.
S. 1465 / HR 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 2484 / HR 4442: CONNECT for Health Act; Section 303 HR 2948: Medicare Telehealth Parity Act of 2015, Section 105(a)(1) HR 5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models. Preservation of the in-office ancillary exception to the Stark law; urging changes to the Meaningful Use Program and Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2016 · second_quarter · Q2
S. 2511: Improving Health Information Technology Act S. 1465 / HR 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 2484: HR 4442: CONNECT for Health Act; Section 303 S. 2978: Protect Continuing Physician Education and Patient Care Act HR 2948: Medicare Telehealth Parity Act of 2015, Section 105(a)(1) HR 5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models. Preservation of the in-office ancillary exception to the Stark law; urging changes to the Meaningful Use Program and Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
S. 2508/ HR 4460: Youth Sports Concussion Act HR 6: 21st Century Cures Act, Title 1, and Sections 1122, & 3021 S. 2782/ HR 1859: Ensuring Childrens Access to Specialty Care Act S. 849 / HR 292: The Advancing Research for Neurological Diseases Act S. 2873 / HR 5395: The Expanding Capacity for Health Outcomes (ECHO) for Act HR 5366: Alzheimers Breakthrough Sunshine Act Maintenance/expansion of Graduate Medical Education (GME); NIH Funding; concussion related issues.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2016 · first_quarter · Q1
S. 737/ H.R. 2253: Ensuring Access to Primary Care for Women & Children Act S. 849 / H.R. 292: The Advancing Research for Neurological Diseases Act S. 1465 / H.R. 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 2118: Ensuring Enhanced Access to Primary Care Act S. 2484/ H.R. 4442: CONNECT for Health Act; Section 303 H.R. 2948: Medicare Telehealth Parity Act of 2015, Section 105(a)(1) Preservation of the in-office ancillary exception to the Stark law; urging changes to the Meaningful Use Program.
S. 2508/ HR 4460: Youth Sports Concussion Act H.R. 6: 21st Century Cures Act, Title 1, and Sections 1122, & 3021 H.R. 1600: Patients' Access to Treatments Act of 2015 Maintenance/expansion of Graduate Medical Education (GME); NIH Funding; concussion related issues
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2015 · fourth_quarter · 4A
S. 737/ H.R. 2253: Ensuring Access to Primary Care for Women & Children Act S. 849 / H.R. 292: The Advancing Research for Neurological Diseases Act S. 1465 / H.R. 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 2118: A bill to amend title XIX of the Social Security Act to extend the application of the Medicare payment rate floor to primary care services furnished under Medicaid and to apply the rate floor to additional providers of primary care services. H.R. 2948: Medicare Telehealth Parity Act of 2015, Section 105(a)(1) Preservation of the in-office ancillary exception to the Stark law; urging changes to the Meaningful Use Program.
H.R. 6: 21st Century Cures Act, Title 1, and Sections 1122, & 3021 H.R. 1600: Patients' Access to Treatments Act of 2015 Maintenance/expansion of Graduate Medical Education (GME); NIH Funding.
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2015 · third_quarter · 3A
H.R. 6: 21st Century Cures Act, Title 1, and Sections 1122, & 3021 H.R. 1600: Patients' Access to Treatments Act of 2015 H.R. 2373: Legitimate Use of Medicinal Marijuana Act Maintenance/expansion of Graduate Medical Education (GME); NIH Funding.
S.141 / H.R. 1190: Protecting Seniors' Access to Medicare Act of 2015 S. 737/ H.R. 2253: Ensuring Access to Primary Care for Women & Children Act S. 849 / H.R. 292: The Advancing Research for Neurological Diseases Act S. 1465 / H.R. 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 2118: A bill to amend title XIX of the Social Security Act to extend the application of the Medicare payment rate floor to primary care services furnished under Medicaid and to apply the rate floor to additional providers of primary care services. H.R. 2948: Medicare Telehealth Parity Act of 2015, Section 105(a)(1) Preservation of the in-office ancillary exception to the Stark law; delay of Meaningful Use State 3.
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2015 · second_quarter · 2A
S. 141 / H.R. 1190: Protecting Seniors' Access to Medicare Act of 2015 S. 849 / H.R. 292: The Advancing Research for Neurological Diseases Act S. 857 / H.R. 1559 Health Outcomes, Planning, and Education (HOPE) for Alzheimers Act of 2015 S. 1465 / H.R. 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 737: Ensuring Access to Primary Care for Women & Children Act S. 1549: Care Planning Act H.R. 2: Medicare Access and CHIP Reauthorization Act of 2015, Title 1 and Section 523. Preservation of the in-office ancillary exception to the Stark law.
S. 683 / HR 1538: CARERS Act of 2015 S. 988 / H.R. 2062: Protecting Student Athletes from Concussions Act of 2015 S. 1475 / H.R. 2603: Saving Lives, Saving Costs Act S. 1073: Stopping Improper Payments to Deceased People Act H.R. 6: 21st Century Cures Act, Title 1, and Sections 1122, & 3021 H.R. 1600: Patients' Access to Treatments Act of 2015 H.R. 1589: Ensuring Childrens Access to Specialty Care Act H.R. 2373: Legitimate Use of Medicinal Marijuana Act Maintenance/expansion of Graduate Medical Education (GME); NIH Funding.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2015 · first_quarter · 1A
S.141 / H.R. 1190: Protecting Seniors' Access to Medicare Act of 2015 S. 849 / H.R. 292: The Advancing Research for Neurological Diseases Act H.R. 2: Medicare Access and CHIP Reauthorization Act of 2015, Title 1 and Section 523. H.R. 270 - Flexibility in Health IT Reporting (Flex-IT) Act of 2015 H.R.639 - Improving Regulatory Transparency for New Medical Therapies Act S. 737: Ensuring Access to Primary Care for Women & Children Act Preservation of the in-office ancillary exception to the Stark law.
S.689 / H.R.921: Sports Medicine Licensure Clarity Act of 2015 H.R. 1006: Building a Health Care Workforce for the Future Act H.R. 1600: Patients' Access to Treatments Act of 2015 21st Century Cures Initiative Maintenance/expansion of Graduate Medical Education (GME); Supporting the Saving Lives Saving Costs Act; Coverage and appropriate use of telemedicine; NIH Funding.
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2015 · fourth_quarter · Q4
H.R. 6: 21st Century Cures Act, Title 1, and Sections 1122, & 3021 H.R. 1600: Patients' Access to Treatments Act of 2015 Maintenance/expansion of Graduate Medical Education (GME); NIH Funding.
S. 737/ H.R. 2253: Ensuring Access to Primary Care for Women & Children Act S. 849 / H.R. 292: The Advancing Research for Neurological Diseases Act S. 1465 / H.R. 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 2118: A bill to amend title XIX of the Social Security Act to extend the application of the Medicare payment rate floor to primary care services furnished under Medicaid and to apply the rate floor to additional providers of primary care services. H.R. 2948: Medicare Telehealth Parity Act of 2015, Section 105(a)(1) Preservation of the in-office ancillary exception to the Stark law; urging changes to the Meaningful Use Program.
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2015 · third_quarter · Q3
H.R. 6: 21st Century Cures Act, Title 1, and Sections 1122, & 3021 H.R. 1600: Patients' Access to Treatments Act of 2015 H.R. 2373: Legitimate Use of Medicinal Marijuana Act Maintenance/expansion of Graduate Medical Education (GME); NIH Funding.
S.141 / H.R. 1190: Protecting Seniors' Access to Medicare Act of 2015 S. 737/ H.R. 2253: Ensuring Access to Primary Care for Women & Children Act S. 849 / H.R. 292: The Advancing Research for Neurological Diseases Act S. 1465 / H.R. 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 2118: A bill to amend title XIX of the Social Security Act to extend the application of the Medicare payment rate floor to primary care services furnished under Medicaid and to apply the rate floor to additional providers of primary care services. H.R. 2948: Medicare Telehealth Parity Act of 2015, Section 105(a)(1) Preservation of the in-office ancillary exception to the Stark law; delay of Meaningful Use State 3.
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2015 · second_quarter · Q2
S. 141 / H.R. 1190: Protecting Seniors' Access to Medicare Act of 2015 S. 849 / H.R. 292: The Advancing Research for Neurological Diseases Act S. 857 / H.R. 1559 Health Outcomes, Planning, and Education (HOPE) for Alzheimers Act of 2015 S. 1465 / H.R. 2799: Furthering Access to Stroke Telemedicine (FAST) Act S. 737: Ensuring Access to Primary Care for Women & Children Act S. 1549: Care Planning Act H.R. 2: Medicare Access and CHIP Reauthorization Act of 2015, Title 1 and Section 523. Preservation of the in-office ancillary exception to the Stark law.
S. 683 / HR 1538: CARERS Act of 2015 S. 988 / H.R. 2062: Protecting Student Athletes from Concussions Act of 2015 S. 1475 / H.R. 2603: Saving Lives, Saving Costs Act S. 1073: Stopping Improper Payments to Deceased People Act H.R. 6: 21st Century Cures Act, Title 1, and Sections 1122, & 3021 H.R. 1600: Patients' Access to Treatments Act of 2015 H.R. 1589: Ensuring Childrens Access to Specialty Care Act H.R. 2373: Legitimate Use of Medicinal Marijuana Act Maintenance/expansion of Graduate Medical Education (GME); NIH Funding.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2015 · first_quarter · Q1
S.689 / H.R.921: Sports Medicine Licensure Clarity Act of 2015 H.R. 1006: Building a Health Care Workforce for the Future Act H.R. 1600: Patients' Access to Treatments Act of 2015 21st Century Cures Initiative Maintenance/expansion of Graduate Medical Education (GME); Supporting the Saving Lives Saving Costs Act; Coverage and appropriate use of telemedicine; NIH Funding.
S.141 / H.R. 1190: Protecting Seniors' Access to Medicare Act of 2015 S. 849 / H.R. 292: The Advancing Research for Neurological Diseases Act H.R. 2: Medicare Access and CHIP Reauthorization Act of 2015, Title 1 and Section 523. H.R. 270 - Flexibility in Health IT Reporting (Flex-IT) Act of 2015 H.R.639 - Improving Regulatory Transparency for New Medical Therapies Act S. 737: Ensuring Access to Primary Care for Women & Children Act Preservation of the in-office ancillary exception to the Stark law.
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2014 · fourth_quarter · 4A
H.R. 460: Patients' Access to Treatments Act H.R. 1098/ S. 2539: Traumatic Brain Injury Reauthorization Act Coverage and appropriate use of telemedicine, VA Epilepsy Centers of Excellence, NIH
S. 755 / H.R. 1838: Enhanced Access to Medicaid Services Act of 2013: H.R.5364: CHIP Extension and Improvement Act of 2014: Sec. 304. Payment parity for Medicaid primary care services H.R.5353: Medicaid Parity Act of 2014 H.R. 5458: The Building a Health Care Workforce for the Future Act H.R. 5481, the Flexibility in Health IT Reporting (Flex-IT) Act HR 5723 / S. 2694: Ensuring Access to Primary Care for Women & Children Act S. 3007: Ensuring Enhanced Access to Primary Care Act Maintenance/expansion of Graduate Medical Education (GME); Permanent repeal to the sustainable growth rate (SGR) formula; Preservation of the in-office ancillary exception to the Stark law
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2014 · fourth_quarter · Q4
S. 755 / H.R. 1838: Enhanced Access to Medicaid Services Act of 2013: H.R.5364: CHIP Extension and Improvement Act of 2014: Sec. 304. Payment parity for Medicaid primary care services H.R.5353: Medicaid Parity Act of 2014 H.R. 5458: The Building a Health Care Workforce for the Future ActH.R. 5481, the Flexibility in Health IT Reporting (Flex-IT) Act HR 5723 / S. 2694: Ensuring Access to Primary Care for Women & Children Act S. 3007: Ensuring Enhanced Access to Primary Care Act Maintenance/expansion of Graduate Medical Education (GME); Permanent repeal to the sustainable growth rate (SGR) formula; Preservation of the in-office ancillary exception to the Stark law
H.R. 460: Patients' Access to Treatments Act H.R. 1098/ S. 2539: Traumatic Brain Injury Reauthorization Act Coverage and appropriate use of telemedicine, VA Epilepsy Centers of Excellence, NIH
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2014 · third_quarter · Q3
S. 755/ H.R. 1838: Enhanced Access to Medicaid Services Act of 2013: H.R.5364: CHIP Extension and Improvement Act of 2014: Sec. 304. Payment parity for Medicaid primary care services H.R.5353: Medicaid Parity Act of 2014 S. 2694: Ensuring Access to Primary Care for Women & Children ActH.R. 5304: Audiology Patient Choice Act of 2014 Maintenance/expansion of Graduate Medical Education (GME); Permanent repeal to the sustainable growth rate (SGR) formula; Preservation of the in-office ancillary exception to the Stark law, Reimbursement and use of chronic care management codes; Elimination of global surgical periods; Retention of the CME exclusion in the Sunshine Act; Reimbursement and use of magnetoencephalography codes; Fair valuation, utilization and access to NCS/EMG services
H.R. 4552: Equestrian Helmet Safety Act H.R. 460: Patients' Access to Treatments Act H.R. 1098/ S. 2539: Traumatic Brain Injury Reauthorization Act Coverage and appropriate use of telemedicine, VA Epilepsy Centers of Excellence, NIH, Dissemination of safety alerts (FDA)
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2014 · second_quarter · Q2
H.R. 460, Patients' Access to Treatments Act H.R. 1098/ S. 2539, Traumatic Brain Injury Reauthorization Act H.R. 1508/ S. 1091, Alzheimers Disease Research Semipostal StampCoverage and appropriate use of telemedicine, VA Epilepsy Centers of Excellence, NIH, SSA medical criteria in evaluating neurological disorders including seizures, Dissemination of safety alerts
S. 577 / HR 1180, Resident Physician Shortage Reduction Act of 2013: Graduate medical education-residency training S. 755/ H.R. 1838, Enhanced Access to Medicaid Services Act of 2013: Amends title XIX (Medicaid) of the Social Security Act H.R. 1173, Personalize Your Care Act of 2013: Voluntary advance care planning consultation in Medicare H.R. 1201, Training Tomorrow's Doctors Today Act: Graduate medical education-residency trainingH.R. 4106, Saving Lives, Saving Costs Act: Provides safe harbors for practitioners following evidence based guidelines H.R. 4695, Amends title XVIII (Medicare) of the Social Security Act to include in the initial preventive physical examination covered under the Medicare program sleep apnea screening Permanent repeal to the sustainable growth rate (SGR) formula; CMS coverage for oxygen for cluster headaches; Preservation of the in-office ancillary exception to the Stark law, Advocate for reimbursement and use of advance care planning; Challenges developing meaningful quality of life measures, Episode of care document and early detection tools for mild cognitive impairment
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2014 · first_quarter · Q1
H.R.460, Patients' Access to Treatments Act of 2013: Establish cost-sharing limits for health plans that cover prescription drugs; Coverage and appropriate use of telemedicine; Extension for 2014 CEHRT criteria and allowing greater flexibility in meeting MU criteria; FDA regarding their review process of clinical trials for multiple sclerosis; DEA regarding the schedule II classification of DaTscan
H.R. 574, Medicare Physician Payment Innovation Act of 2013: Medicare physician payment-sustainable growth rate (SGR) reform S. 577 / HR 1180, Resident Physician Shortage Reduction Act of 2013: Graduate medical education-residency training S. 755/ H.R. 1838, Enhanced Access to Medicaid Services Act of 2013: Amends title XIX (Medicaid) of the Social Security Act H.R. 1173, Personalize Your Care Act of 2013: Voluntary advance care planning consultation in MedicareH.R. 1201, Training Tomorrow's Doctors Today Act: Graduate medical education-residency training S. 2000/ H.R. 4015, SGR Repeal and Medicare Provider Payment Modernization Act of 2014: Medicare physician payment-sustainable growth rate (SGR) reform S. 2046 / H.R. 4035: To amend title XVIII of the Social Security Act to provide Medicare beneficiaries coordinated care and greater choice with regard to accessing hearing health services and benefits. S. 2110, Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014: Medicare physician payment-sustainable growth rate (SGR) reform H.R. 2810, Medicare Patient Access and Quality Improvement Act: Medicare physician payment-sustainable growth rate (SGR) reform H.R. 4106, Saving Lives, Saving Costs Act: Provides safe harbors for practitioners following evidence based guidelines H.R. 4302, Protecting Access to Medicare Act of 2014: Changes to Medicare physician payment-sustainable growth rate (SGR) formula Preservation of the in-office ancillary exception to the Stark law; ACO exclusivity issues; Protected class status criteria; ICD 10 transition and implementation; Commented on CMS RFI on specialty practitioner payment model opportunities.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2013 · fourth_quarter · Q4
Support for enhanced treatment options for Traumatic Brain Injury and Post-Traumatic Stress Disorder as included in Section 733 of HR 1960, the FY2014 National Defense Authorization Act; Support for the preservation and expansion of the graduate medical education funding; Support for improved concussion safety standards for youth athletics including supporting Protecting Student Athletes from Concussions Act (HR 3532/ S 1546);Support for the expanded and appropriate use of telemedicine; Support the reduction/elimination of specialty tiers within private health plans including supporting HR 460, the Patients' Access to Treatments Act of 2013; Opposing sequestration cuts to NIH research; Submitted comment letter voicing our concerns with the transition to stage 2 MU and the 2014 EHR certification criteria; Submitted comments via sign on letter requesting CMS exclude articles from journals and medical textbooks from reporting under the Sunshine Act.
Support for permanent repeal and replacement of the Medicare SGR; Provided comments on payment reform to the House Ways and Means and Energy and Commerce Committees and Senate Finance Committee; Support payment reform to more accurately value cognitive care services; Support the preservation of the in-office ancillary exception to the Stark law;Supporting the Enhanced Access to Medicaid Services Act (HR 1838/ S 755) which would add neurology, psychiatry, and Ob/Gyn to the ACA Medicaid at Medicare rates provision; Submitted comments via signon letter raising concerns with Medicare Advantage health plans network adequacy and process for notifying physicians about contract terminations; Met with senior staff to discuss neurology specific issues such as cognitive reimbursement, quality measurement and new payment delivery models; Discussed stroke episode of care and other payment models with CMMI staff; Discussed early detection of measures for AD and dementia with quality and coverage staff.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2013 · third_quarter · Q3
Support permanent repeal and replacement of the Medicare SGR including HR 2810 as well as supporting HR 574 the Medicare Physician Payment Innovation Act of 2013; Support payment reform to more accurately value cognitive care services; Opposing automatic sequestration cuts to Medicare provider payments; Supporting the Enhanced Access to Medicaid Services Act (HR 1838/ S 755) which adds neurology, psychiatry, and Ob/Gyn to the ACA Medicaid at Medicare rates provision;Support for the preservation of the in-office ancillary exception to the stark law; Support for the Health Outcomes, Planning, and Education for Alzheimer's Act (S.709 /H.R.1507) which provides support for appropriate diagnosis and treatment of Alzheimers Disease; Sent a letter to CMS supporting their coverage decision regarding beta amyloid imaging along with some suggestions; Discuss stroke episode of care model with Centers for Medicare and Medicaid Innovation staff; Work with CMS to share concerns and offer an alternative proposal for the APC assignment of EMG and NCS codes in the 2014 OPPS proposed rule; Submitted comments to CMS on the 2014 MPFS and 2014 OPPS proposed rules; Advocated for improvements to complex chronic care coordination codes proposal; Participated on refinement panel to argue for higher work RVUs for EMG and NCS codes.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2013 · second_quarter · 2A
Support permanent repeal and replacement of the Medicare SGR including commenting on House Energy and Commerce/Ways and Means proposals and supporting HR 574 the Medicare Physician Payment Innovation Act of 2013; Support payment reform to more accurately value cognitive care services; Support repeal of the ACAs Independent Payment Advisory Board (H.R. 351/S. 351); Opposing automatic sequestration cuts to Medicare provider payments;Supporting the Enhanced Access to Medicaid Services Act (HR 1838/ S 755) which adds neurology, psychiatry, and Ob/Gyn to the ACA Medicaid at Medicare rates provision; Support for the preservation of the in-office ancillary exception to the stark law; Submitted recommendations to CMS on how to improve health information exchange physicians; Submitted comments to CMS on the Physician Part B filing proposed rule; Submitted comments to CMS in opposition of primary care only E/M codes; Submitted comments to CMS on the 2014 Inpatient Prospective Payment Systems proposed rule; Submitted comments to CMS on how clinical quality measures can be enhanced to better meet physicians needs; Met with CMS to discuss role of AAN in innovative delivery models and preparing our members for the changing healthcare landscape.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2013 · first_quarter · 1A
Support increasing appropriations for NIH including specific centers and initiatives. Support increased funding for the VA Epilepsy Centers of Excellence; Opposing NIH cuts called for by sequestration; Support federal medical malpractice liability reform; Support for maintaining the Stark In-Office Ancillary Services Exception, Support for broad physician payment reform; Support HR 460 for patient access to biologic drugs;Commented on expanding the list of diagnosable illnesses as secondary conditions to service-connected TBI to include dementia, sleep and wake disorders and mild TBI.
Support permanent repeal and replacement of the Medicare SGR including supporting HR 574, Medicare Physician Payment Innovation Act of 2013; Support payment reform to more accurately value cognitive care services; Support repeal of the PPACAs Independent Payment Advisory Board (H.R. 351/S. 351) ; Opposing automatic sequestration cuts to Medicare Provider Payments; Supporting the inclusion of various E/M based specialties in the Medicaid at Medicare rates provision of the ACA;Advocated for refinement panel to examine more appropriate valuation of nerve conduction and EMG services; Recommended the removal of cognitive physicians from the 5.9% cut to the conversion factor proposed by MedPAC; Advocating for reimbursement of complex chronic care coordination codes under Medicare; Nominating an individual for appointment to MedPAC.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2013 · first_quarter · Q1
Support permanent repeal and replacement of the Medicare SGR including supporting HR 574, Medicare Physician Payment Innovation Act of 2013; Support payment reform to more accurately value cognitive care services; Support repeal of the PPACAs Independent Payment Advisory Board (H.R. 351/S. 351) ; Opposing automatic sequestration cuts to Medicare Provider Payments; Supporting the inclusion of various cognitive specialties in the ACA Medicaid at Medicare rates provision of the ACA;Advocated for refinement panel to examine more appropriate valuation of nerve conduction and EMG services; Recommended inclusion of cognitive physicians in expanded definition of primary care and removal of cognitive physicians from 5.9% cut to the conversion factor proposed by MedPAC; Advocating for reimbursement of complex chronic care coordination codes under Medicare.
Support increasing appropriations for NIH including specific centers and initiatives, and the VA Epilepsy Centers of Excellence; Opposing NIH cuts called for by sequestration; Support federal medical malpractice liability reform; Support for maintaining the Stark In-Office Ancillary Services Exception, Support for broad physician payment reform; Support HR 460 for patient access to biologic drugs;Commented on expanding the list of diagnosable illnesses as secondary conditions to service-connected TBI to include dementia, sleep and wake disorders and mild TBI.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2012 · fourth_quarter · Q4
Increasing NIH appropriations for FY2013 and opposing NIH cuts called for by sequestration; Support federal medical malpractice liability reform (HR. 5); Support protections for neurology patients participating in clinical trial participant; Support for maintaining the Stark In-Office Ancillary Services Exception, Support for broad physician payment reform; Support HR 4209 for patient access to biologic drugs; Advocating for changes in bills to promote Graduate Medical Education, HR 6352 and HR 6352, to remove list of eligible specialties; Support for neurology's inclusion in pediatric loan repayment programs offered by the Affordable Care Act; Oppose creating an exclusivity period for drugs that treat neurological and psychiatric diseases; Support expedited FDA review for drugs treating neurological and psychiatric diseases; Offered recommendations to improve the MEPS survey.
Permanent repeal or patch of the Medicare SGR prior to any cut taking effect; Payment reform to more accurately value cognitive care services; Support HR 5707, Medicare Physician Payment Innovation Act of 2012; Support repeal of the PPACAs Independent Payment Advisory Board; Support HR. 3269 / S. 2347 to eliminate the multiple procedure payment reduction (MPPR) on professional components for select advanced diagnostic imaging services; Opposing automatic sequestration cuts to Medicare Provider Payments; Supporting the inclusion of various cognitive specialties in the 2013 Medicaid provider payments at Medicaid rates; Advocated for better reimbursement for nerve conduction and EMG services and intra-operative neurophysiology monitoring; Advocated to change global period 64615 to 0 day; Opposed expansion of the RAC program to include audits of E/M codes in physician offices; Commented on aspects of the essential health benefits proposal; requesting that neurodevelopmental disorders and dementias be excluded from the umbrella of mental health and included separately.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2012 · third_quarter · Q3
Increasing NIH appropriations for FY2013 and opposing NIH cuts called for by sequestration; Support federal medical malpractice liability reform (HR. 5); Support protections for neurology patients participating in clinical trial participant; Support for maintaining the Stark In-Office Ancillary Services Exception, Support for physician payment reform; Support HR 4209 for patient access to biologic drugs; Advocating for changes in bills to promote Graduate Medical Education, HR 6352 and HR 6352, to remove list of eligible specialties; Support for neurology's inclusion in pediatric loan repayment programs offered by the Affordable Care Act; Commenting on health information technology enabled quality measures
Permanent repeal or patch of the Medicare SGR prior to any cut taking effect; Payment reform to more accurately value cognitive care services; Support HR 5707, Medicare Physician Payment Innovation Act of 2012; Support repeal of the PPACAs Independent Payment Advisory Board; Support HR. 3269 / S. 2347 to eliminate the multiple procedure payment reduction (MPPR) on professional components for select advanced diagnostic imaging services; Opposing automatic sequestration cuts to Medicare Provider Payments; Nominated 2 members to serve on the Medicare Evidence Development Coverage Advisory Committee; Transitional care management and chronic care coordination codes.
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2012 · second_quarter · Q2
Increasing NIH appropriations for FY2013; Support federal medical malpractice liability reform (HR. 5); Support protections for neurology patients participating in clinical trial participant; Support for maintaining the Stark In-Office Ancillary Services Exception, Support physician payment reform; Support for Alzheimers Disease specific appropriations; Support HR 4209 for patient access to biologic drugs; Support Appropriations for Biomedical Advanced Research and Development Authority (BARDA); Support inclusion of migraine/posttraumatic headache as an eligible category within the Congressionally Directed Medical Research Program.
Permanent repeal or patch of the Medicare SGR prior to any cut taking effect; Payment reform to more accurately value cognitive care services; Support HR 5707, Medicare Physician Payment Innovation Act of 2012; Support repeal of the PPACAs Independent Payment Advisory Board; Support HR. 3269 / S. 2347 to eliminate the multiple procedure payment reduction (MPPR) on professional components for select advanced diagnostic imaging services; Administrative Simplification: Adoption of a Standard for a Unique Health Plan Identifier; Addition to the National Provider Identifier Requirements; and a Change to the Compliance Date for ICD-10-CM and ICD-10-PCS Medical Data Codes Sets; Changes to the Hospital Inpatient and Long-Term Care Prospective Payment System for FY 2013 Medicaid Program: Payments for Services Furnished by Certain Primary Care Physicians Medicare and Medicaid Programs: Electronic Health Record Incentive Program--Stage 2 Proposed Rule
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2012 · first_quarter · Q1
Permanent repeal or patch of the Medicare SGR prior to any cut taking effect; Payment reform to more accurately value cognitive care services; HR 5 Repeal of the PPACAs Independent Payment Advisory Board and Medical Malpractice Reform.
Increasing NIH appropriations to $35 billion for FY2013; Support federal medical malpractice liability reform (HR. 5); Support protections for neurology patients participating in clinical trial participant; Support for maintaining the Stark In-Office Ancillary Services Exception, Support inclusion of migraine/posttraumatic headache as an eligible catagory within the Congressionally Directed Medical Reseach Program, Support for a congressional hearing on headache/migraine, Support TBI Act reauthorization. Support for further investment in the development of new antibiotics, Commenting on the implimentation of the National Alzheimer Project Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2011 · fourth_quarter · Q4
Permanent repeal or patch of the Medicare SGR prior to any cut taking effect; inclusion of neurology in the PPACAs primary care bonus (S. 587/HR. 2224); Payment reform to more accurately value cognitive care services; Repeal of the PPACAs Independent Payment Advisory Board (HR. 452/ S. 668)
Increasing NIH appropriations to $35 billion for FY2012; Federal medical malpractice liability reform (HR. 5); Ensuring protections for neurology patients participating in clinical trial participant; Opposition to the Integrity in Medicare Advanced Diagnostic Imaging Act of 2011 (HR 1476); Support for the Children's Sports Athletic Equipment Safety Act (S. 601/ HR 1127), Supporting HR 3328 to provide a six-month grace period to help those opening advanced medical imaging facilities.
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2011 · third_quarter · Q3
Permanent repeal or patch of the Medicare SGR prior to the 2012 cut taking effect; Inclusion of neurology in the PPACAs primary care bonus (S. 587/HR. 2224); Payment reform to more accurately value cognitive care services; Repeal of the PPACAs Independent Payment Advisory Board (HR. 452/ S. 668)
Increasing NIH appropriations to $35 billion for FY2012; Federal medical malpractice liability reform (HR. 5); Supporting bonding bill to enhance Alzheimers research (HR. 610); Ensuring protections for neurology patients participating in clinical trial participant; Opposition to the Integrity in Medicare Advanced Diagnostic Imaging Act of 2011 (HR 1476); Support for the Children's Sports Athletic Equipment Safety Act (S. 601/ HR 1127).
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
AMERICAN ACADEMY OF NEUROLOGY via AMERICAN ACADEMY OF NEUROLOGY
2011 · second_quarter · Q2
Opposition to the Integrity in Medicare Advanced Diagnostic Imaging Act of 2011 (HR 1476). Support for increased NIH funding for research on headache, stroke other neurologic conditions. Support for the Help Efficient, Accessible, Low-cost, Timely Healthcare Act of 2011 (HR 5 / S 218). Support for the Children's Sports Athletic Equipment Safety Act (S. 601).
Support for adding neurology to the primary care incentive of the Patient Protection and Affordable Care Act (ACA), specifically supporting S 597 and section 3 of HR 2224. Support for efforts to encourage CMS to restore consultation codes. Support for the elimination of the Sustainable Growth Rate formula under Medicare. Support for S 668 / HR 452 to repeal the Independent Payment Advisory Board established by the ACA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 368/ H.R. 1332: Telehealth Modernization Act S. 754/ H.R. 1916: Ensuring Lasting Smiles Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 S. 1988/H.R. 5425: Protecting Rural Telehealth Access Act H.R. 366: Protecting Access to Post-COVID-19 Telehealth Act H.R. 3173: Improving Seniors Timely Access to Care Act H.R. 3447: Permanency for Audio-Only Telehealth Act H.R. 4040: Advancing Telehealth Beyond Covid-19 Act S. 1731: Medicare Audiologist Access and Services Act Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D.
S. 464/ H.R. 2163: Safe Step Act
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program.
H.R. 2079: The Eliminating the Provider Relief Fund Tax Penalties Act of 2021
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program.
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 Support for creating a Neuroscience Center of Excellence at FDA Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage. Support for funding the CDC National Neurological Conditions Surveillance System. Medical research funding related to fetal tissue, AHRQ, Congressionally Directed Medical Research Programs at the Department of Defense, and the NIH including the BRAIN Initiative. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
H.R. 2079: The Eliminating the Provider Relief Fund Tax Penalties Act of 2021
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R. 2079: The Eliminating the Provider Relief Fund Tax Penalties Act of 2021
S. 289/ H.R. 869: Research Investment to Spark the Economy (RISE) Act S. 610/ H.R. 16 67: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 Support for creating a Neuroscience Center of Excellence at FDA Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including funding for personal protective equipment, maintaining telemedicine coverage, and ensuring access to affordable health coverage. Support for funding the CDC National Neurological Conditions Surveillance System. Medical research funding related to fetal tissue, AHRQ, and the NIH including the BRAIN Initiative. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program.
S. 464/ H.R. 2163: Safe Step Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Strengthening the VA Centers of Excellence
S. 348/H.R. 1763 Resident Physician Shortage Reduction Act of 2019; all provisions. S. 2443: Investment in Tomorrow's Pediatric Health Care Workforce Act; all provisions. S. 2546 / H.R. 2279: Safe Step Act; all provisions. S. 3599/H.R. 6788: Healthcare Workforce Resilience Act; all provisions. S. 3741/ H.R. 6644: The Health Care at Home Act; all provisions. S. 3993: The Equal Access to Care Act; all provisions. S. 4421/ H.R. 8283: the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act. S. 7819/H.R. 4525 Eliminating the Provider Relief Fund Tax Penalties Act of 2020; all provisions. H.R.133: The Consolidated Appropriations Act, 2021, Division H Title II Department of Health and Human Services; Division BB, Titles I, No Surprises Act. H.R. 2781: Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act, section 4. H.R. 3502: Protecting People from Surprise Medical Bills Act; all provisions. H.R. 6800: The Heroes Act; Title VI and Title X Division C. H.R. 7059: The Coronavirus Provider Protection Act; all provisions. H.R. 7255: Coronavirus Health Care Worker Wellness Act of 2020; all provisions. Supporting policies to address the COVID-19 public health emergency, including funding for personal protective equipment, maintaining telemedicine coverage, ensuring access to affordable health coverage, and medical liability flexibility relating to COVID-19. Funding for the CDC National Neurological Conditions Surveillance System. Medical research funding related to fetal tissue, AHRQ, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Policy to address surprise medical billing. Promoting interoperability in electronic health records. Maintain work authorization for individuals currently in DACA status during the COVID-19 national emergency and other policies to support health care providers who live, work, and train in the United States but are not US citizens.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
S. 3988: The Enhancing Preparedness Through Telehealth Act; all provisions. H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions. H.R. 4932/ S. 2741: CONNECT for Health Act; all provisions. H.R. 7391, The Protect Telehealth Access Act; all provisions. H.R. 7663: Protecting Access to Post-COVID-19 Telehealth Act; all provisions. Supporting the implementation of CMSs final rule on Evaluation and Management (E/M) billing codes. Supporting policies to address the COVID-19 pandemic, including expanding telemedicine, support for physician practices, and regulatory relief. Supporting a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. Improvements to the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015. Medicare coverage of oxygen therapy for cluster headaches. Advocating for reform to stark and anti-kickback laws to promote value-based payment arrangements.
Strengthening the VA Centers of Excellence
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
S. 2443: Investment in Tomorrow's Pediatric Health Care Workforce Act; all provisions. S. 2546 / H.R. 2279: Safe Step Act; all provisions. H.R. 2781: Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act, section 4. H.R. 748: Coronavirus Aid, Relief and Economic Security (CARES) Act; Title III. H.R. 3502: Protecting People from Surprise Medical Bills Act; all provisions. H.R. 6800: The Heroes Act; Title VI and Title X Division C. H.R. 6644/S. 3741, The Health Care at Home Act; all provisions. H.R. 7059, the Coronavirus Provider Protection Act; all provisions. S. 3993, The Equal Access to Care Act; all provisions. Supporting policies to address the COVID-19 public health emergency, including funding for personal protective equipment, maintaining telemedicine coverage, ensuring access to affordable health coverage, and medical liability flexibility relating to COVID-19. Funding for the CDC National Neurological Conditions Surveillance System. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, AHRQ, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Lifting the federal ban restricting HHS from studying a Universal Patient Identifier. Policy to address surprise medical billing. Promoting interoperability in electronic health records. Maintain work authorization for individuals currently in DACA status during the COVID-19 national emergency and other policies to support health care providers who live, work, and train in the United States but are not US
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
S. 2543: Prescription Drug Pricing Reduction Act; sections 102, 107, 110, 121, 128, 141. H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act; all provisions. H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions. Supporting policies to address the COVID-19 pandemic, including expanding telemedicine, support for physician practices, and regulatory relief. Supporting CMSs final rule on Evaluation and Management (E/M) billing codes. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. Improvements to the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015. Medicare coverage of oxygen therapy for cluster headaches. Advocating for reform to stark and anti-kickback laws to promote value-based payment arrangements.
Strengthening the VA Centers of Excellence
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act; all provisions. H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019; all provisions. H.R. 2282: Medicare Care Coordination Improvement Act of 2019; all provisions. H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. CMS proposed rule altering Evaluation and Management billing codes. Issues associated with defining a rehabilitation physician within the inpatient rehabilitation setting. Improvements to the Medicare Access and CHIP Reauthorization Act of 2015. Appropriate use criteria for imaging services. Medicare coverage of oxygen therapy for cluster headaches.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
H.R. 88; Section 505: Repeal of Unrelated Business Income Tax on Qualified Transportation Fringe Benefits
Strengthening the VA Centers of Excellence
S. 1384/ H.R. 3805: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 2387: We Protect American Investment in Drugs (PAID) Act; all provisions. S.2443: Investment in Tomorrow's Pediatric Health Care Workforce Act; all provisions. S. 2546 / H.R. 2279: Safe Step Act; all provisions. H.R. 1865: Further Consolidated Appropriations Act, 2020; priorities within this package around outlined below. H.R. 2781: Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act, section 4. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. H.R. 3502, Protecting People from Surprise Medical Bills Act; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Lifting the federal ban restricting HHS from studying a Universal Patient Identifier. Policy to address surprise medical billing. Promoting interoperability in electronic health records
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
S. 2543: Prescription Drug Pricing Reduction Act; sections 102, 107, 110, 121, 128, 141. HR 3: Lower Drug Costs Now Act of 2019; all provisions. H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions. Excluding non-invasive ventilators from the 2021 competitive bidding program CMS proposed rule altering Evaluation and Management and long-term electroencephalogram (EEG) billing codes. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. Improvements to the Medicare Access and CHIP Reauthorization Act of 2015. Medicare coverage of oxygen therapy for cluster headaches.
Strengthening the VA Centers of Excellence
H.R. 88; Section 505: Repeal of Unrelated Business Income Tax on Qualified Transportation Fringe Benefits
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
S. 73: End Taxpayer Subsidies for Drug Ads Act; all provisions. S. 348/H.R. 1763: Support the Resident Physician Shortage Reduction Act of 2019; all provisions. S. 427 / H.R. 1058: Autism CARES Act of 2019; all provisions. S. 948/ H.R. 2895: Conrad State 30 and Physician Access Reauthorization Act; all provisions. S. 1384: Prescription Drug Rebate Reform Act of 2019; all provisions. S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 3032: Cannabidiol and Marijuana Research Expansion Act; all provisions. H.R. 1155: Preventing Unkind and Painful Procedures and Experiments on Respected Species Act of 2019; all provisions. H.R. 2113: Prescription Drug STAR Act: Sections 2 and 5 H.R. 2279: Safe Step Act; all provisions. H.R. 3030: Patient-Centered Outcomes Research Extension Act of 2019; all provisions. H.R. 3439: Protecting Access to Information for Effective and Necessary Treatment (PATIENTS) Act of 2019; all provisions. Supporting policies to address prescription drug costs, including improving drug pricing transparency and eliminating or reducing direct-to-consumer advertising. Funding for the National Neurological Conditions Surveillance System and opposing certain expansions to this program. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Raising budget caps to avoid sequestration. Policy to address surprise medical billing. Promoting interoperability in electronic health records.
H.R. 88; Section 505: Repeal of Unrelated Business Income Tax on Qualified Transportation Fringe Benefits
Strengthening the VA Centers of Excellence
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Strengthening the VA Centers of Excellence
S. 61 / H.R. 478: Safe and Affordable Drugs from Canada Act S. 73: End Taxpayer Subsidies for Drug Ads Act S. 97 / H.R. 447: Affordable and Safe Prescription Drug Importation Act S. 350/H.R. 1418: Competitive Health Insurance Reform Act of 2019 H.R. 171: Legitimate Use of Medicinal Marijuana Act H.R. 1585: Violence Against Women Reauthorization Act of 2019 H.R. 2279: Safe Step Act PCORI Reauthorization; Eliminating DTC prescription pharmaceutical CDC funding for research into firearm morbidity and mortality prevention; Policy to address surprised medical billing; Promoting interoperability in electronic health records; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues; loan repayment for pediatric specialists.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
S. 92: Safe and Affordable Drugs from Canada Act S. 469: Affordable and Safe Prescription Drug Importation Act S. 1131/ H.R. 2439: FAIR Drug Pricing Act S. 1348: SPIKE Act of 2017 S. 1369/ H.R. 2974: Stop Price Gouging Act S. 1803/H.R. 4825, the Marijuana Effective Drug Studies (MEDS) Act S. 2076/H.R. 4256: BOLD Infrastructure for Alzheimer's Act S. 2406: Advancing Cutting Edge (ACE) Research Act S. 2478: End Taxpayer Subsidies for Drug Ads Act S. 2680: Opioid Crisis Response Act S. 2891: Fighting the Opioid Epidemic with Sunshine Act S. 3369/ HR 6689: Ensuring Lasting Smiles Act S. 3411/H.R. 6689: Affordable Medications Act S. 3657/ H.R. 6615: Traumatic Brain Injury Program Reauthorization Act S. 3686/ H.R. 3580: Protecting Student Athletes from Concussions Act H.R. 6: SUPPORT for Patients and Communities Act: Sections 6062 and 6111; Subtitle E H.R. 1776: Improving Access to Affordable Prescription Drugs Act H.R. 2077: Restoring the Patient's Voice Act H.R. 3391, Medical Marijuana Research Act of 2017 H.R. 4116: Transparent Drug Pricing Act H.R. 5634: Medical Cannabis Research Act H.R. 6340: Capping Prescription Costs Act Disclosure of drug prices in prescription drug direct-to-consumer advertising; Sustained fetal tissue research; Orphan Drug Act Reform; Interoperability, including for Qualified Clinical Data Registries; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues; loan repayment for pediatric specialists.
Strengthening the VA Centers of Excellence
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 5520: VA Medicinal Cannabis Research Act of 2018
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Strengthening the VA Centers of Excellence
H.R. 88; Section 505: Repeal of Unrelated Business Income Tax on Qualified Transportation Fringe Benefits
S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 2908: Legislation to improve electronic prior authorization use in Medicare Advantage S. 2051/H.R. 4206: Medicare Care Coordination Improvement Act H.R. 4841: Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018 Qualified clinical data registries (QCDR) measure licensing; Step Therapy in Medicare Advantage; CMS proposed rule altering Evaluation and Management billing codes; appropriate use criteria for imaging services; CDC Neurological Conditions Surveillance System funding; Medicare coverage of oxygen therapy for cluster headaches.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 2908: Legislation to improve electronic prior authorization use in Medicare Advantage S. 2051/H.R. 4206: Medicare Care Coordination Improvement Act H.R. 4841: Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018 Step Therapy in Medicare Advantage; CMS proposed rule altering Evaluation and Management billing codes; appropriate use criteria for imaging services; Medicare coverage of oxygen therapy for cluster headaches.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 5520: VA Medicinal Cannabis Research Act of 2018
S. 2575: Audiology Patient Choice Act of 2018 S. 2908: Legislation to improve electronic prior authorization use in Medicare Advantage S. 3120: Helping to End Addiction and Lessen (HEAL) Substance Use Disorders Act of 2018 H.R. 4841: Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018 Preservation of the in-office ancillary exception to the Stark law; appropriate use criteria for imaging services; Medicare coverage of oxygen therapy for cluster headaches.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 260 / H.R. 849: Protecting Seniors Access to Medicare Act S. 431 / H.R. 1148: Furthering Access to Stroke Telemedicine (FAST) Act S. 870 / H.R. 4579: CHRONIC Care Act S. 1016 / H.R. 2556: CONNECT for Health Act Preservation of the in-office ancillary exception to the Stark law; appropriate use criteria for imaging services; Medicare coverage of oxygen therapy for cluster headaches; urging changes to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1. Preservation of deductibility of student loan interest and medical expenses; Preservation of tax-exempt status for graduate tuition waivers; opposition to repealing the individual mandate.
Preserving national funding for the Epilepsy Centers of Excellence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 260 / H.R. 849: Protecting Seniors Access to Medicare Act S. 431 / H.R. 1148: Furthering Access to Stroke Telemedicine (FAST) Act S. 870 / H.R. 4579: CHRONIC Care Act S. 1016 / H.R. 2556: CONNECT for Health Act S. 2051: The Medicare Care Coordination Improvement Act of 2017 Preservation of the in-office ancillary exception to the Stark law; appropriate use criteria for imaging services; Medicare coverage of Oxygen therapy for cluster headaches; urging changes to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
VA Epilepsy Centers of Excellence, NIH, Alzheimers Research, and the pediatric loan repayment program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Support for the preservation and expansion of the graduate medical education funding; Support for improved concussion safety standards for youth athletics including supporting Protecting Student Athletes from Concussions Act (S.1546); Support for the expanded and appropriate use of telemedicine; Support S 1027 to improve, coordinate, and enhance rehabilitation research at the NIH;Support the reduction/elimination of specialty tiers within private health plans including supporting HR 460, Patients' Access to Treatments Act of 2013; Opposing automatic sequestration cuts to NIH research; Support the Pharmaceutical Quality, Security, and Accountability Act (S. 959); Nominated Dr. John C. Morris to serve as a physician/researcher on the Advisory Council on Alzheimer's Care, Research and Services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Support for the preservation and expansion of the graduate medical education funding; Support for more research funds for Alzheimers Disease and other dementias including NIH appropriations and private funding models as outlined in HR 1619, the Making Investments Now for Dementia (MIND) Act of 2013; Support for improved concussion safety standards for youth athletics including supporting HR 2118 / S 1014, the Youth Sports Concussion Act of 2013;Support for the expanded and appropriate use of telemedicine; Support S 1027 to improve, coordinate, and enhance rehabilitation research at the NIH; Support the reduction/elimination of specialty tiers within private health plans including supporting HR 460, Patients' Access to Treatments Act of 2013; Support for credential disclosure by health care providers in HR 1427, the Truth in Health Marketing Act of 2013; Opposing automatic sequestration cuts to NIH research; Submitted recommendations to the FDA on the proposed guidance document on Alzheimers disease research; Submitted recommendations to the Assistant Secretary of Planning and Evaluation on what topics should be included in measuring physicians time and work.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE
Advocating for continued funding for the VA Epilepsy Centers of Excellence.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE